RFK JR: BARDA is terminating 22 mRNA vaccine development investments

BARDA is terminating 22 mRNA vaccine development investments because the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu. We’re shifting that funding toward
AUG 5, 2025